within Pharmacolibrary.Drugs.R_RespiratorySystem.R02A_ThroatPreparations.R02AB04_Bacitracin;

model Bacitracin
  extends Pharmacolibrary.Drugs.ATC.R.R02AB04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>R02AB04</td></tr><td>route:</td><td>intramuscular</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Bacitracin is a polypeptide antibiotic primarily used for topical treatment of bacterial infections, including skin and eye infections. It is active mainly against Gram-positive bacteria. Bacitracin is rarely used systemically due to nephrotoxicity and poor absorption from the gastrointestinal tract. Its systemic use is now uncommon and primarily historical. It is an approved drug but mostly used topically.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for bacitracin after intramuscular administration in adults based on available summaries and limited animal data. No directly referenced clinical PK studies in humans were found.</p><h4>References</h4><ol><li><p>Wang, J, et al., &amp; Zhang, Q (2006). Pharmacokinetics, toxicity of nasal cilia and immunomodulating effects in Sprague-Dawley rats following intranasal delivery of thymopentin with or without absorption enhancers. <i>Peptides</i> 27(4) 826–835. DOI:<a href=&quot;https://doi.org/10.1016/j.peptides.2005.09.008&quot;>10.1016/j.peptides.2005.09.008</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16242213/&quot;>https://pubmed.ncbi.nlm.nih.gov/16242213</a></p></li><li><p>Wüthrich, P, et al., &amp; Buri, P (1994). Effect of formulation additives upon the intranasal bioavailability of a peptide drug: tetracosactide (ACTH1-24). <i>Pharmaceutical research</i> 11(2) 278–282. DOI:<a href=&quot;https://doi.org/10.1023/a:1018915710318&quot;>10.1023/a:1018915710318</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8165188/&quot;>https://pubmed.ncbi.nlm.nih.gov/8165188</a></p></li><li><p>Ericsson, CD, et al., &amp; Qadri, SM (1979). Systemic absorption of bacitracin after peritoneal lavage. <i>American journal of surgery</i> 137(1) 65–67. DOI:<a href=&quot;https://doi.org/10.1016/0002-9610(79)90012-6&quot;>10.1016/0002-9610(79)90012-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/758843/&quot;>https://pubmed.ncbi.nlm.nih.gov/758843</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Bacitracin;
